TKD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Takeda Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 26.16 EUR 0.11%

Market Cap: €41.6B

	Takeda Pharmaceutical Co Ltd F:TKD	JP
M	Mandom Corp F:MD9	JP
F	Fufeng Group Ltd XMUN:FFO1	CN
D	Douyu International Holdings Ltd F:DY8A	CN
	Innate Pharma SA NASDAQ:IPHA	FR
D	DPC Dash Ltd OTC:DPCDF	CN
E	Exponent Inc F:EP5	US
I	IDEX Corp F:ID7	US
	Innate Pharma SA F:IDD	FR
	EDA Group Holdings Ltd F:7OZ	CN
A	Ameresco Inc F:4AM	US
E	Energizer Holdings Inc F:EGG	US

Profitability Summary

Takeda Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

69% > 65%

Healthy Operating Margin

11%

Sustainable 3Y Average Operating Margin

11%

Declining Operating Margin

14% > 11%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

8% > 3%

Exceptional Free Cash Flow Margin

17%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.